Korean generic makers win Plavix patent lawsuit

Korea's 17 generic makers have won the right to market Plavix (clopidogrel bisulfate) as a local patent court ruled on January 18 that Sanofi-Aventis's original patent is already expired.

However, experts say that a patent war surrounding Plavix patent will become fiercer as Sanofi-Aventis Korea were determined to defend its original patent with all possible legal means.

Last June, a pate...